期刊
ACTA PHARMACOLOGICA SINICA
卷 35, 期 7, 页码 937-944出版社
ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/aps.2014.37
关键词
lithospermate B; transition metal complex; drug metabolism; metabolite; methylation; Na+/K+-ATPase inhibitor; danshen; traditional Chinese medicine
资金
- National Chung-Hsing University, Taiwan, China [NCHU-102D604]
Aim: Lithospermate B (LSB) isolated from the traditional Chinese medicine danshen (Salvia miltiorrhiza) is an effective N+/K+-ATPase inhibitor and used to treat congestive heart failure. The inhibition of LSB on Na+/K+-ATPase is potentiated by forming complexes with transition metal ions. Here we investigated the safety and metabolites of different transition metal-LSB complexes in rats. Methods: LSB complexed with six different transition metal ions (Mg2+, Zn2+, Cr3+, Co2+, Ni2+ and Mn2+) were prepared. Adult male SD rats were injected with the different metal-LSB complexes (50 mg/kg, iv), and their bile and blood samples were collected. The metabolites of the metal-LSB complexes in the samples were analyzed using mass spectroscopy. Results: In rats injected with LSB complexed with Mg2+, Zn2+, Cr3+, Ni2+ or Mn2+, LSB and its four putative metabolites were equivalently detected in their bile samples. Mn2+-LSB exhibited distinct metabolite profiles compared with the other four metal-LSB complexes. The four putative metabolites were identified as 3-monomethyl-LSB, 3,3 ''-dimethyl-LSB, 3,3'''-dimethyl-LSB and 3,3 '',3'''-trimethyl-LSB. The tracking of successive bile samples of rats injected with Mg2+-LSB, Zn2+-LSB and Mn2+-LSB concurrently demonstrated that LSB was firstly methylated at position 3, then at position 3 '', and, finally, the 3''' hydroxyl group. All rats injected with Co2+-LSB died. Conclusion: Zn2+-LSB, Cr3+-LSB, Ni2+-LSB or Mn2+-LSB produces identical four methylated metabolites of LSB in rats, and seemed to be as safe as LSB or Mg2+-LSB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据